That's okay. I will accept that on the record.
I know that I'm to assume that in this privatized market, this commodified market of life-saving vaccines, big pharma companies like Moderna and Pfizer are ultimately making the decision on where vaccines go. We see this in the global trends: wealthy countries that have the money by nature get prioritized. I think you and I have had exchanges on prioritization in the past.
I'm wondering if that continues to be the case, or is there a scenario in place, based on the purchases versus options scenario that you and I exchanged quite a bit on, whereby if Moderna and Pfizer decide to jack up the prices, we might expect delays on our lower-cost-per-unit contracts in favour of a higher commodified and urgent deal somewhere else?